European drug wholesaler Abacus secures investor to fund growth
Danish drug merchant Abacus Medicine will
sell 48 million euros ($53 million) worth of new shares to
investment firm Chr. Augustinus Fabrikker after it called off a
planned share listing in May.
sell 48 million euros ($53 million) worth of new shares to
investment firm Chr. Augustinus Fabrikker after it called off a
planned share listing in May.
Posted by Reuters
